Koezuka Y - Search Results

1

Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers.

Matsuda JL, Naidenko OV, Gapin L, Nakayama T, Taniguchi M, Wang CR, Koezuka Y, Kronenberg M. Matsuda JL, et al. Among authors: koezuka y. J Exp Med. 2000 Sep 4;192(5):741-54. doi: 10.1084/jem.192.5.741. J Exp Med. 2000. PMID: 10974039 Free PMC article.

2

Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines.

Gonzalez-Aseguinolaza G, Van Kaer L, Bergmann CC, Wilson JM, Schmieg J, Kronenberg M, Nakayama T, Taniguchi M, Koezuka Y, Tsuji M. Gonzalez-Aseguinolaza G, et al. Among authors: koezuka y. J Exp Med. 2002 Mar 4;195(5):617-24. doi: 10.1084/jem.20011889. J Exp Med. 2002. PMID: 11877484 Free PMC article.

3

CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution.

Brossay L, Chioda M, Burdin N, Koezuka Y, Casorati G, Dellabona P, Kronenberg M. Brossay L, et al. Among authors: koezuka y. J Exp Med. 1998 Oct 19;188(8):1521-8. doi: 10.1084/jem.188.8.1521. J Exp Med. 1998. PMID: 9782129 Free PMC article.

4

CD1-mediated antigen presentation of glycosphingolipids.

Naidenko OV, Koezuka Y, Kronenberg M. Naidenko OV, et al. Among authors: koezuka y. Microbes Infect. 2000 May;2(6):621-31. doi: 10.1016/s1286-4579(00)00363-4. Microbes Infect. 2000. PMID: 10884613 Free article. Review.

5

Glycolipid antigen processing for presentation by CD1d molecules.

Prigozy TI, Naidenko O, Qasba P, Elewaut D, Brossay L, Khurana A, Natori T, Koezuka Y, Kulkarni A, Kronenberg M. Prigozy TI, et al. Among authors: koezuka y. Science. 2001 Jan 26;291(5504):664-7. doi: 10.1126/science.291.5504.664. Science. 2001. PMID: 11158680

6

The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice.

Hong S, Wilson MT, Serizawa I, Wu L, Singh N, Naidenko OV, Miura T, Haba T, Scherer DC, Wei J, Kronenberg M, Koezuka Y, Van Kaer L. Hong S, et al. Among authors: koezuka y. Nat Med. 2001 Sep;7(9):1052-6. doi: 10.1038/nm0901-1052. Nat Med. 2001. PMID: 11533710

7

Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis.

Jahng AW, Maricic I, Pedersen B, Burdin N, Naidenko O, Kronenberg M, Koezuka Y, Kumar V. Jahng AW, et al. Among authors: koezuka y. J Exp Med. 2001 Dec 17;194(12):1789-99. doi: 10.1084/jem.194.12.1789. J Exp Med. 2001. PMID: 11748280 Free PMC article.

8

Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells.

Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Sato H, Kondo E, Harada M, Koseki H, Nakayama T, Tanaka Y, Taniguchi M. Kawano T, et al. Among authors: koezuka y. Proc Natl Acad Sci U S A. 1998 May 12;95(10):5690-3. doi: 10.1073/pnas.95.10.5690. Proc Natl Acad Sci U S A. 1998. PMID: 9576945 Free PMC article.

9

Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes.

Burdin N, Brossay L, Koezuka Y, Smiley ST, Grusby MJ, Gui M, Taniguchi M, Hayakawa K, Kronenberg M. Burdin N, et al. Among authors: koezuka y. J Immunol. 1998 Oct 1;161(7):3271-81. J Immunol. 1998. PMID: 9759842

10

Syntheses of biotinylated alpha-galactosylceramides and their effects on the immune system and CD1 molecules.

Sakai T, Naidenko OV, Iijima H, Kronenberg M, Koezuka Y. Sakai T, et al. Among authors: koezuka y. J Med Chem. 1999 May 20;42(10):1836-41. doi: 10.1021/jm990054n. J Med Chem. 1999. PMID: 10346936

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters